Leukapheresis Market Overview
The global Leukapheresis market is expected to witness a double-digit growth rate by 2031. Increasing cancer prevalence, rising research and development investments, growing utilization of leukopaks for research, expanding demand for personalized medicine, and supportive government initiatives are among the major factors expected to drive market growth.
Leukapheresis is an extracorporeal blood-processing procedure used to selectively remove white blood cells from a patient’s blood. It has an important role in managing certain hematological malignancies, particularly leukemia, where extremely elevated white blood cell counts can lead to leukostasis and potentially affect vital organs.
High white blood cell counts can contribute to symptoms such as vision disturbances, breathing difficulties, and impaired oxygen exchange. Leukapheresis can be used as a therapeutic intervention in selected patients and may also be performed to collect a patient’s own blood cells for subsequent transplantation or other therapeutic applications.
Beyond clinical applications, leukapheresis is increasingly relevant to biomedical research. Leukopaks obtained through leukapheresis contain concentrated white blood cells and are valuable research materials for immunology, cell therapy development, cancer research, drug discovery, and personalized medicine.
Leukapheresis Market Trends
Growing Utilization of Leukopaks in Research
The increasing use of leukopaks in research and biotechnology is creating new opportunities for the leukapheresis market. Leukopaks provide researchers with concentrated populations of immune cells that can be used in studies involving cellular therapies, immunological disorders, cancer biology, vaccine development, and drug discovery.
The expansion of cell and gene therapy research is further increasing interest in high-quality human immune-cell sources. Pharmaceutical companies, biotechnology companies, academic institutions, and research organizations are increasingly using leukapheresis-derived materials to support preclinical and translational research.
Increasing Demand for Personalized Medicine
The shift toward personalized and precision medicine is another important market trend. Personalized therapies often require patient-specific cellular materials, making efficient cell collection and processing technologies increasingly important.
The growth of cellular immunotherapies and other advanced therapeutic approaches is expected to create additional demand for leukapheresis procedures, devices, and consumables. Improvements in cell separation technologies are also supporting the development of more efficient approaches for collecting targeted blood cell populations.
Impact of COVID-19 on the Leukapheresis Market
The COVID-19 pandemic disrupted healthcare workflows and temporarily affected several medical procedures. However, leukapheresis also gained attention during the pandemic because of its potential application in studying immune responses and blood-related changes associated with SARS-CoV-2 infection.
COVID-19 was associated with lymphopenia in many patients, prompting researchers to investigate the effects of the virus on lymphocytes, immune responses, and blood coagulation. Leukapheresis provided a method for collecting white blood cells for research purposes.
For instance, in May 2020, the National Institutes of Health Clinical Center, together with the National Institute of Allergy and Infectious Diseases, initiated a clinical study using leukapheresis to investigate how SARS-CoV-2 affected lymphocytes, the immune system, and blood clotting mechanisms in individuals who had recovered from COVID-19.
Leukapheresis Market Segmentation
The global leukapheresis market can be segmented based on product, method, application, end user, and region.
By product, the market is categorized into devices and disposables.
By method, the market is divided into centrifugation, membrane separation, and selective adsorption.
By application, the market is classified into therapeutic applications and research applications.
By end user, the market includes blood centers, hospitals, and other healthcare and research organizations. The others category includes research institutes, biopharmaceutical manufacturers, and private medical settings.
Regionally, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America includes the U.S., Canada, and Mexico, while major European markets include Germany, France, the U.K., Italy, and Spain. Asia-Pacific includes Japan, China, Australia, India, South Korea, and other regional markets. LAMEA includes Brazil, Saudi Arabia, South Africa, and other countries.
Leukapheresis Market Segment Analysis
Disposables Segment
Based on product, disposables accounted for a major share of the leukapheresis market and are expected to maintain a strong position during the forecast period. The increasing prevalence of leukemia and the growing number of leukapheresis procedures are contributing to demand for disposable components.
Single-use products are particularly important in leukapheresis because they can reduce the risk of cross-contamination and infection associated with blood-processing procedures. The growing emphasis on patient safety and infection control is therefore expected to support demand for leukapheresis disposables.
Centrifugation Segment
Based on method, centrifugation represented a major portion of the market. Centrifugation-based systems are widely used for separating blood components according to differences in density and have established applications in therapeutic apheresis.
The increasing installation of centrifugal apheresis systems in hospitals and blood-processing facilities is supporting segment growth. Equipment developed by major manufacturers, including the Spectra Optia Apheresis System from Terumo BCT, has contributed to the availability of advanced centrifugal blood-cell separation technologies.
Membrane Separation Segment
The membrane separation segment is expected to register strong growth during the forecast period. Increasing interest in alternative cell separation approaches, technological advancements, and the growing need for efficient leukocyte collection are supporting adoption.
The increasing prevalence of leukemia and other hematological conditions is expected to create additional demand for technologies capable of selectively separating blood components.
Leukapheresis Market Growth Factors
Rising Prevalence of Hematological Malignancies
The growing burden of leukemia and other blood-related cancers is a major factor supporting demand for leukapheresis procedures. Selected patients with high white blood cell counts may require therapeutic leukapheresis to reduce leukocyte levels and manage complications associated with leukostasis.
The increasing focus on early diagnosis and treatment of hematological malignancies is also contributing to demand for specialized blood-processing technologies.
Expansion of Cell Therapy and Biomedical Research
Growing investment in cell-based therapies, immunotherapy, drug development, and translational research is expanding the potential applications of leukapheresis. Leukapheresis-derived cellular materials can serve as important inputs for research and development programs involving immune cells.
Increasing collaboration between pharmaceutical companies, biotechnology firms, research institutions, and healthcare organizations is expected to further expand opportunities for leukapheresis technology providers.
Increasing Demand for Single-Use Products
Leukapheresis procedures require multiple disposable components, making consumables an important contributor to market revenue. Single-use systems can support infection prevention and simplify workflow management by reducing the need for complex reprocessing.
As healthcare facilities place greater emphasis on infection control and operational efficiency, demand for disposable leukapheresis products is expected to remain strong.
Regional Outlook
North America is expected to remain an important market for leukapheresis due to increasing awareness of blood donation, established healthcare infrastructure, higher healthcare expenditure, and supportive government initiatives. The region also benefits from the presence of major medical technology and biotechnology companies.
Asia-Pacific is anticipated to experience notable growth during the forecast period. Increasing healthcare expenditure, expanding healthcare infrastructure, growing investments in medical device manufacturing, and rising awareness of advanced blood-processing technologies are expected to support regional expansion.
Emerging economies may provide additional opportunities as healthcare systems invest in advanced therapeutic procedures and research capabilities.
Key Players
- Asahi Kasei Medical
- Haemonetics Corporation
- Terumo BCT
- Miltenyi Biotec
- Fresenius
- Caltag Medsystems
- Macopharma
- Lonza Group
- Charles River Laboratories
- Zen-Bio
Leukapheresis Market Outlook
The global leukapheresis market is expected to maintain strong growth through 2031, supported by the increasing prevalence of leukemia, expansion of cell and gene therapy research, growing utilization of leukopaks, rising demand for personalized medicine, and continued technological development in blood-cell separation.
The increasing demand for blood components and cellular materials is expected to create attractive opportunities for manufacturers of leukapheresis systems and disposable products. Furthermore, the expansion of therapeutic apheresis and advanced cell-based therapies is likely to encourage companies to develop more efficient, automated, and specialized leukapheresis technologies.
The combination of growing clinical demand and expanding research applications is expected to make leukapheresis an increasingly important component of modern blood processing, cellular research, and advanced therapeutic development.
Get Free Sample Report: https://meditechinsights.com/global-leukapheresis-market/request-sample/
About Medi-Tech Insights
Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.
